World's Best Scientists 2026 revealed!
Romano Danesi

Romano Danesi

D-Index & Metrics

Medicine

D-Index
80
Citations
21825
World Ranking
17186
National Ranking
693

Overview

Romano Danesi is affiliated with the University of Pisa in Italy and has contributed extensively to the fields of medicine, particularly oncology and pulmonary and respiratory medicine. Their scholarly work spans multiple subfields including molecular biology, cancer research, and genetics.

Their recent publications reflect focus areas in cancer treatment and diagnostics, immune-related complications, and disease-modifying therapies. Notable papers include:

  • "Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment" (2022, ESMO Open)
  • "The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies" (2021, ESMO Open)
  • "Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis" (2021, Journal of Neurology)
  • "Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance" (2021, Drug Safety)
  • "Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours" (2022, Cancer Treatment Reviews)

Frequent co-authors who have collaborated with Danesi include Marzia Del Re, Stefania Crucitta, Stefano Fogli, Federico Cucchiara, and Annalisa Capuano. The extent of collaboration ranges, with some co-authors contributing to numerous joint publications.

Danesi's research is often published in recurrent scientific venues, notably:

  • ESMO Open
  • Critical Reviews in Oncology/Hematology
  • Cancers
  • Cancer Treatment Reviews
  • Frontiers in Oncology

Their main fields of study focus on Medicine and Biochemistry, Genetics and Molecular Biology. Subfields prominent in their research include oncology, pulmonary and respiratory medicine, molecular biology, cancer research, and genetics.

Key topics addressed in Danesi's work relate to:

  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Advanced Breast Cancer Therapies
  • Renal cell carcinoma treatment
  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies

Best Publications

  • Molecular basis of resistance to azole antifungals

    Antonella Lupetti;Romano Danesi;Mario Campa;Mario Del Tacca

  • MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

    Elisa Giovannetti;Niccola Funel;Godefridus J. Peters;Marco Del Chiaro

  • Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

    Elisa Giovannetti;Mario Del Tacca;Valentina Mey;Niccola Funel

  • Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial.

    Chiara Cremolini;Daniele Rossini;Emanuela Dell’Aquila;Sara Lonardi

  • Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

    Alex Sparreboom;Romano Danesi;Yuichi Ando;Juliana Chan

  • Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

    C. Tibaldi;E. Giovannetti;E. Vasile;V. Mey

  • Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs

    Romano Danesi;Stefano Fogli;Alessandra Gennari;Pierfranco Conte

  • The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

    Marzia Del Re;Elisa Biasco;Stefania Crucitta;Lisa Derosa

  • Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.

    Elisa Giovannetti;Valentina Mey;Sara Nannizzi;Giuseppe Pasqualetti

  • Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer

    Akinobu Hamada;Tristan Sissung;Douglas K. Price;Romano Danesi

  • PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

    Marzia Del Re;Riccardo Marconcini;Giulia Pasquini;Eleonora Rofi

  • The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

    Lokesh Jain;Craig A. Vargo;Romano Danesi;Tristan M. Sissung

  • Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma.

    Lorenza Rimassa;Romano Danesi;Tiziana Pressiani;Philippe Merle

  • Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer

    Francesco Crea;Elaine M Hurt;Lesley A Mathews;Stephanie M Cabarcas

  • Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

    Elisa Giovannetti;Elisa Giovannetti;Ayse Erozenci;Jorn Smit;Romano Danesi

  • Biweekly Chemotherapy With Oxaliplatin, Irinotecan, Infusional Fluorouracil, and Leucovorin: A Pilot Study in Patients With Metastatic Colorectal Cancer

    Alfredo Falcone;Gianluca Masi;Giacomo Allegrini;Romano Danesi

  • The pharmacological bases of the antiangiogenic activity of paclitaxel

    Guido Bocci;Antonello Di Paolo;Romano Danesi

  • Cardiac toxicity of antineoplastic anthracyclines.

    Riccardo Zucchi;Romano Danesi

  • Clinical pharmacology of intravitreal anti-VEGF drugs.

    Stefano Fogli;Marzia Del Re;Eleonora Rofi;Chiara Posarelli

  • EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

    Francesco Crea;Lorenzo Fornaro;Guido Bocci;Lei Sun

Frequent Co-Authors

Alfredo Falcone
Alfredo Falcone University of Pisa
Elisa Giovannetti
Elisa Giovannetti VU University Medical Center
Fotios Loupakis
Fotios Loupakis Istituto Oncologico Veneto
Pierfranco Conte
Pierfranco Conte University of Padua
Gabriella Fontanini
Gabriella Fontanini University of Pisa
William D. Figg
William D. Figg National Institutes of Health
Godefridus J. Peters
Godefridus J. Peters Gdańsk Medical University
Ron H.N. van Schaik
Ron H.N. van Schaik Erasmus University Rotterdam
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Camillo Porta
Camillo Porta University of Bari Aldo Moro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of online degrees and allied health careers. For those aiming for advanced practice, cheap dnp online programs can provide a flexible and cost-effective path to a Doctor of Nursing Practice, ideal for nurses seeking leadership roles.

Pharmacy is another promising field, and online pharmacist programs enable students to prepare for pharmacy licensure at a distance, making it easier to balance studies and work.

Not all healthcare roles require an advanced medical degree. Entry points like a him associate degree online let you start a career in healthcare data and records management, a growing industry with competitive salaries.

Additionally, medical billing and coding online courses can equip you for in-demand administrative roles. These programs are often short and affordable and offer a convenient way into healthcare support services.

Best Scientists Citing Romano Danesi

Trending Scientists

Recently Published Articles